Balance Sheet
Cash Flow Statement
Cash from Financing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Palisade Bio (PALI) Other Working Capital Changes (2016 - 2025)

Historic Other Working Capital Changes for Palisade Bio (PALI) over the last 16 years, with Q3 2025 value amounting to $603000.0.

  • Palisade Bio's Other Working Capital Changes rose 41243.52% to $603000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $329000.0, marking a year-over-year increase of 15053.76%. This contributed to the annual value of -$750000.0 for FY2024, which is 638.3% down from last year.
  • Per Palisade Bio's latest filing, its Other Working Capital Changes stood at $603000.0 for Q3 2025, which was up 41243.52% from $1000.0 recorded in Q2 2025.
  • In the past 5 years, Palisade Bio's Other Working Capital Changes ranged from a high of $603000.0 in Q3 2025 and a low of -$516000.0 during Q3 2022
  • Its 5-year average for Other Working Capital Changes is -$124000.0, with a median of -$174500.0 in 2024.
  • As far as peak fluctuations go, Palisade Bio's Other Working Capital Changes crashed by 69189.19% in 2023, and later soared by 41243.52% in 2025.
  • Quarter analysis of 5 years shows Palisade Bio's Other Working Capital Changes stood at -$39000.0 in 2021, then plummeted by 625.64% to -$283000.0 in 2022, then soared by 61.48% to -$109000.0 in 2023, then plummeted by 90.83% to -$208000.0 in 2024, then soared by 389.9% to $603000.0 in 2025.
  • Its last three reported values are $603000.0 in Q3 2025, $1000.0 for Q2 2025, and -$67000.0 during Q1 2025.